Tendonitis Treatment Market Size To Rise USD 298.12 Bn By 2032

Published Date : 26 Dec 2023

The global tendonitis treatment market size exceeded USD 210.02 billion in 2022 and is expected to rise to USD 298.12 billion by 2032, growing at a CAGR of 3.57% during the forecast period from 2023 to 2032.

Tendonitis Treatment Market Size and Growth Rate From 2023 To 2032

Market Overview

Tendonitis can be defined as the inflammation of a tendon that may result in swelling. Tendons are strands of connective tissue found between muscles and bones and that aid movement. Tendonitis can be either long-term or short-term and can cause joint pain and stiffness and affect how a tendon moves. This is also associated with repetitive movements such as running, jumping, or throwing, poor work posture, strain from sudden movements, or an injury. Although there is no specific age for the condition, it is common in adults above. Some underlying medical conditions, such as diabetes, osteoarthritis, rheumatoid arthritis, infection, and others, can also cause tendonitis.

There are various treatment options, such as physical therapy, over-the-counter (OTC) pain relievers, and required surgical procedures. In minor cases, tendinitis can be treated at home with rest, ice, and some pain reliever medicine. In some instances, people with severe tendonitis are prescribed stronger therapeutics, such as steroids, which may provide short-term pain relief or surgery to replace damaged tissue or restore a torn tendon. Suppose the pain is severe or difficulties in the movement are limited. In that case, an individual prefers physiotherapy, and if the pain lasts long, then an individual visits an orthopedic specialist, a doctor who specializes in muscles and bones, or a local musculoskeletal clinic.      

The tendonitis treatment market is found to be driven by factors such as supportive government initiatives, advancement in technology, increasing investment in the healthcare infrastructure, growing cases of sports-related injuries, increasing geriatric population, rising awareness among people about tendonitis, and increasing prevalence of orthopedic disorders. Additionally, the rapid innovations in tendon replacement and regeneration techniques are likely to impact the market’s growth. Furthermore, the market is growing as a result of increasing demand for effective treatment for tendonitis in emerging markets, which is expected to fuel the market’s expansion.

Regional Insights

North America is expected to dominate the market during the forecast period due to the rising prevalence of orthopaedic surgeries, increasing spending on healthcare advancement, the presence of prominent market players, sophisticated healthcare facilities, rising geriatric population, and rising consumer disposable income.

The United States accounted for the larger revenue share in the region. The factors affecting the growth of the country, such as increasing research and development activities, increasing number of surgeries performed for tendonitis, and rapid advancement in the healthcare sector, have resulted in the development of new technologies and equipment, which is likely to fuel the market’s expansion in the U.S. tendonitis treatment market. According to the report published by Golden State Orthopaedics & Spine (GSOS) in 2022, tennis elbow is very common and affects more than 200,000 people in the U.S. annually. People aged 30 to 50 are most commonly affected. Any repetitive activity that involves twisting of the wrist can cause this condition. Therefore, a significant number of injuries may increase the demand for its treatment and boost the market. Several market players in the region are undertaking various initiatives to expand their business footprint, such as partnerships or collaborations among established and renowned players, acquisitions, and new product launches.

In April 2023,a US-based medical technology company, Vander-Bend Manufacturing, Inc., announced the acquisition of Omni Components Corporation. Through this acquisition, Vander-Bend Manufacturing aims to boost its capabilities and expand its manufacturing footprint to the Northeast and Southwest.

Tendonitis Treatment Market Report Scope

Report Coverage Details
Market Revenue in 2023 USD 217.41 Billion
Projected Forecast Revenue by 2032 USD 298.12 Billion
Growth Rate from 2023 to 2032 CAGR of 3.57%
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Market Dynamics


The rising burden of sports injuries

The increasing number of cases of sports injuries is anticipated to propel the tendonitis treatment market's growth during the forecast period. Tendonitis usually affects people who play sports such as running, jumping, tennis, basketball, skating, dancing, handball, cricket, and football. According to a study presented at the 2023 American Academy of Orthopedic Surgeons (AAOS) annual meeting. The study 'Epidemiology of Sports Injuries Among High School Athletes in the United States' found that an estimated 5,228,791 sports injuries occurred nationally. In addition, football has reported the highest number of injuries, at over 1.5 million each year. 40% of all football injuries are sprains and strains. Thus, sports injuries in youngsters are prevalent and are expected to contribute to the growth of the market.

Rise in advanced therapies and technologies

Market players across the globe are constantly investing in innovating advanced therapies and technologies for managing tendonitis, which is projected to fuel the growth of the tendonitis treatment market. Tendonitis is generally caused by ageing, overweight, and injury and commonly affects tendons in the elbows, shoulders, wrists, knees, hips, and ankles. Healthcare facilities provide treatment for tendonitis, which includes physical therapy, rest, OTC medications (including ibuprofen and naproxen), and, in some critical cases, surgical procedures. The goal of the treatment is to help patients manage pain and regain mobility in the affected tendons. Physical therapy is the emerging treatment for tendonitis owing to the increasing effectiveness of strengthening in treating chronic tendon conditions.


High cost of treatment

The tendonitis treatment market's expansion is anticipated to be constrained by the high cost of tendonitis treatment. The high treatment cost of tendinitis during surgeries, including the cost of service and hospital stay, is often too much for most of the population in emerging economies. This may act as a hindrance for cost-sensitive consumers. Middle and lower-income families are discouraged from spending on surgeries due to budget constraints, thereby hampering the market growth over the forecast period.

Lack of awareness

Due to the lack of awareness about the condition and its advanced treatments in undeveloped countries, treatment is not often administered. Additionally, side effects associated with the treatment and prolonged inactivity, which cause stiff joints, are likely to limit the expansion of the global tendonitis treatment market.


Rising product launches

The rise in product launches is estimated to create substantial market growth opportunities during the forecast period. In addition, the key players operating in the market are also constantly increasing healthcare expenditures to gain a competitive edge in the global market.

  • In July 2023, Smith+Nephew, the global medical technology company, announced the launch of its REGENETEN Bioinductive Implant in India. With more than 100,000 procedures completed since its introduction. The collagen-based REGENETEN supports the body's natural healing response to facilitate the growth of new tendon-like tissue.

Growing geriatric population

The rising geriatric population is expected to propel the growth of the global tendonitis treatment market during the forecast period as the aging population is more susceptible to chronic tendons. Tendonitis causes pain, problems in mobility, and less muscle strength. The increasing incidence of bone disorders, osteoarthritis, diabetes, osteoporosis, and rheumatoid arthritis makes the aging population more susceptible to tendonitis. As per the United Nations World Social Report 2023, the number of persons aged 65 years or older across the globe. The rising cases of age-related diseases have spurred the demand for tendonitis treatment globally.

Recent Developments

  • In May 2023, Camber Consumer Care launched naproxen sodium tablets to relieve pain in several conditions, such as headaches, muscle aches, tendonitis, dental pain, and menstrual cramps. It also reduces pain, swelling, and joint stiffness caused by arthritis, bursitis, and gout attacks. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID).
  • In May 2022, CoNextions Inc.), an innovator in tendon repair, announced only nineteen days after FDA 510(k) clearance to market the device, the first patient was treated with the CoNextions TR™ Tendon Repair System in a zone 2 flexor tendon in the little finger.

Key Market Players

  • Teva Pharmaceuticals Industries
  • Almatica Pharma, Inc.
  • GlaxoSmithKline PLC
  • Abbott
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Pfizer
  • AstraZeneca
  • Bayer AG
  • Merck and Co., Inc.

Market Segmentation

By Treatment

  • Surgery
  • Therapy

By Condition

  • Achilles Tendonitis
  • Swimmer’s Shoulder
  • Jumper’s Knee
  • Pitcher’s Elbow
  • Golfer’s Elbow
  • Tennis Elbow

Buy this Research Report@ https://www.precedenceresearch.com/checkout/3396

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333